CPHA Canvax

"This document provides a summary of the updated NACI recommendations on the interchangeability of authorized COVID-19 vaccines. These recommendations are based on current scientific evidence and NACI's expert opinion." -  Summary of National Advisory Committee on Immunization Statement of June 17, 2021

Rating See Comments Ratings


Vaccine Safety and Development,Vaccine Safety,Sub Topics: Vaccine Safety and Development,Adverse Events Following Immunization (AEFI),Research and Development,Vaccine Development,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and Development
Vaccine Safety
Sub Topics: Vaccine Safety and Development
Adverse Events Following Immunization (AEFI)
Research and Development
Vaccine Development
Monitoring and Surveillance
Outbreaks and Pandemics


Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.